| Laura D Sullivan, CRNA | |
|
363 Highland Ave, Fall River, MA 02720-3703 | |
| (508) 679-3131 | |
| Not Available |
| Full Name | Laura D Sullivan |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 26 Years |
| Location | 363 Highland Ave, Fall River, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265433122 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 256715 (Massachusetts) | Primary |
| 367500000X | Nurse Anesthetist, Certified Registered | 001968 (Connecticut) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Partners Of New England Llc | 2365835428 | 25 |
News Archive
River blindness, or onchocerciasis, is a disease caused by a parasitic worm found primarily in Africa. The worm (Onchocerca volvulus) is transmitted to humans as immature larvae through bites of infected black flies.
Lawmakers, patient-privacy and health care advocates, and information technology experts on Tuesday "debated ... how Congress can strike a balance between accelerating the adoption of a nationwide system of electronic medical records while protecting patient privacy," CongressDaily reports (Noyes, CongressDaily, 6/4).
Politico: States with "the most progressive health policies" are having a hard time implementing their part of a $5 billion series of high-risk insurance pools because their states offer a more generous guarantee of coverage. "Five states — Vermont, Maine, New York, New Jersey and Massachusetts — have 'guaranteed issue' of insurance: individual subscribers cannot be turned away because of a health condition.
An oral anti-clotting drug, when added to standard medical treatment for acute coronary syndrome, lowered the risk of death, heart attack or stroke an average of 16 percent, according to research presented at the American Heart Association's Scientific Sessions.
Tetra Discovery Partners today announced that the company has initiated human Phase 1 safety trials of its lead compound BPN14770, which Tetra is developing as a potential treatment to both improve memory and slow the progression of Alzheimer's disease.
› Verified 6 days ago
| Entity Name | Anaesthesia Associates Of Massachusetts, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568415289 PECOS PAC ID: 5193611267 Enrollment ID: O20040225000842 |
News Archive
River blindness, or onchocerciasis, is a disease caused by a parasitic worm found primarily in Africa. The worm (Onchocerca volvulus) is transmitted to humans as immature larvae through bites of infected black flies.
Lawmakers, patient-privacy and health care advocates, and information technology experts on Tuesday "debated ... how Congress can strike a balance between accelerating the adoption of a nationwide system of electronic medical records while protecting patient privacy," CongressDaily reports (Noyes, CongressDaily, 6/4).
Politico: States with "the most progressive health policies" are having a hard time implementing their part of a $5 billion series of high-risk insurance pools because their states offer a more generous guarantee of coverage. "Five states — Vermont, Maine, New York, New Jersey and Massachusetts — have 'guaranteed issue' of insurance: individual subscribers cannot be turned away because of a health condition.
An oral anti-clotting drug, when added to standard medical treatment for acute coronary syndrome, lowered the risk of death, heart attack or stroke an average of 16 percent, according to research presented at the American Heart Association's Scientific Sessions.
Tetra Discovery Partners today announced that the company has initiated human Phase 1 safety trials of its lead compound BPN14770, which Tetra is developing as a potential treatment to both improve memory and slow the progression of Alzheimer's disease.
› Verified 6 days ago
| Entity Name | Southcoast Physicians Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336137629 PECOS PAC ID: 0749171957 Enrollment ID: O20040920000138 |
News Archive
River blindness, or onchocerciasis, is a disease caused by a parasitic worm found primarily in Africa. The worm (Onchocerca volvulus) is transmitted to humans as immature larvae through bites of infected black flies.
Lawmakers, patient-privacy and health care advocates, and information technology experts on Tuesday "debated ... how Congress can strike a balance between accelerating the adoption of a nationwide system of electronic medical records while protecting patient privacy," CongressDaily reports (Noyes, CongressDaily, 6/4).
Politico: States with "the most progressive health policies" are having a hard time implementing their part of a $5 billion series of high-risk insurance pools because their states offer a more generous guarantee of coverage. "Five states — Vermont, Maine, New York, New Jersey and Massachusetts — have 'guaranteed issue' of insurance: individual subscribers cannot be turned away because of a health condition.
An oral anti-clotting drug, when added to standard medical treatment for acute coronary syndrome, lowered the risk of death, heart attack or stroke an average of 16 percent, according to research presented at the American Heart Association's Scientific Sessions.
Tetra Discovery Partners today announced that the company has initiated human Phase 1 safety trials of its lead compound BPN14770, which Tetra is developing as a potential treatment to both improve memory and slow the progression of Alzheimer's disease.
› Verified 6 days ago
| Entity Name | Narragansett Bay Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861445728 PECOS PAC ID: 5991774929 Enrollment ID: O20050714000216 |
News Archive
River blindness, or onchocerciasis, is a disease caused by a parasitic worm found primarily in Africa. The worm (Onchocerca volvulus) is transmitted to humans as immature larvae through bites of infected black flies.
Lawmakers, patient-privacy and health care advocates, and information technology experts on Tuesday "debated ... how Congress can strike a balance between accelerating the adoption of a nationwide system of electronic medical records while protecting patient privacy," CongressDaily reports (Noyes, CongressDaily, 6/4).
Politico: States with "the most progressive health policies" are having a hard time implementing their part of a $5 billion series of high-risk insurance pools because their states offer a more generous guarantee of coverage. "Five states — Vermont, Maine, New York, New Jersey and Massachusetts — have 'guaranteed issue' of insurance: individual subscribers cannot be turned away because of a health condition.
An oral anti-clotting drug, when added to standard medical treatment for acute coronary syndrome, lowered the risk of death, heart attack or stroke an average of 16 percent, according to research presented at the American Heart Association's Scientific Sessions.
Tetra Discovery Partners today announced that the company has initiated human Phase 1 safety trials of its lead compound BPN14770, which Tetra is developing as a potential treatment to both improve memory and slow the progression of Alzheimer's disease.
› Verified 6 days ago
| Entity Name | North American Partners In Anesthesia Massachusetts Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457867020 PECOS PAC ID: 8820350713 Enrollment ID: O20180312001704 |
News Archive
River blindness, or onchocerciasis, is a disease caused by a parasitic worm found primarily in Africa. The worm (Onchocerca volvulus) is transmitted to humans as immature larvae through bites of infected black flies.
Lawmakers, patient-privacy and health care advocates, and information technology experts on Tuesday "debated ... how Congress can strike a balance between accelerating the adoption of a nationwide system of electronic medical records while protecting patient privacy," CongressDaily reports (Noyes, CongressDaily, 6/4).
Politico: States with "the most progressive health policies" are having a hard time implementing their part of a $5 billion series of high-risk insurance pools because their states offer a more generous guarantee of coverage. "Five states — Vermont, Maine, New York, New Jersey and Massachusetts — have 'guaranteed issue' of insurance: individual subscribers cannot be turned away because of a health condition.
An oral anti-clotting drug, when added to standard medical treatment for acute coronary syndrome, lowered the risk of death, heart attack or stroke an average of 16 percent, according to research presented at the American Heart Association's Scientific Sessions.
Tetra Discovery Partners today announced that the company has initiated human Phase 1 safety trials of its lead compound BPN14770, which Tetra is developing as a potential treatment to both improve memory and slow the progression of Alzheimer's disease.
› Verified 6 days ago
| Entity Name | Anesthesia Partners Of New England Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326672312 PECOS PAC ID: 2365835428 Enrollment ID: O20220222002522 |
News Archive
River blindness, or onchocerciasis, is a disease caused by a parasitic worm found primarily in Africa. The worm (Onchocerca volvulus) is transmitted to humans as immature larvae through bites of infected black flies.
Lawmakers, patient-privacy and health care advocates, and information technology experts on Tuesday "debated ... how Congress can strike a balance between accelerating the adoption of a nationwide system of electronic medical records while protecting patient privacy," CongressDaily reports (Noyes, CongressDaily, 6/4).
Politico: States with "the most progressive health policies" are having a hard time implementing their part of a $5 billion series of high-risk insurance pools because their states offer a more generous guarantee of coverage. "Five states — Vermont, Maine, New York, New Jersey and Massachusetts — have 'guaranteed issue' of insurance: individual subscribers cannot be turned away because of a health condition.
An oral anti-clotting drug, when added to standard medical treatment for acute coronary syndrome, lowered the risk of death, heart attack or stroke an average of 16 percent, according to research presented at the American Heart Association's Scientific Sessions.
Tetra Discovery Partners today announced that the company has initiated human Phase 1 safety trials of its lead compound BPN14770, which Tetra is developing as a potential treatment to both improve memory and slow the progression of Alzheimer's disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura D Sullivan, CRNA 53 Tallawanda Rd, Ste. 670, Swansea, MA 02777-1206 Ph: (508) 567-1969 | Laura D Sullivan, CRNA 363 Highland Ave, Fall River, MA 02720-3703 Ph: (508) 679-3131 |
News Archive
River blindness, or onchocerciasis, is a disease caused by a parasitic worm found primarily in Africa. The worm (Onchocerca volvulus) is transmitted to humans as immature larvae through bites of infected black flies.
Lawmakers, patient-privacy and health care advocates, and information technology experts on Tuesday "debated ... how Congress can strike a balance between accelerating the adoption of a nationwide system of electronic medical records while protecting patient privacy," CongressDaily reports (Noyes, CongressDaily, 6/4).
Politico: States with "the most progressive health policies" are having a hard time implementing their part of a $5 billion series of high-risk insurance pools because their states offer a more generous guarantee of coverage. "Five states — Vermont, Maine, New York, New Jersey and Massachusetts — have 'guaranteed issue' of insurance: individual subscribers cannot be turned away because of a health condition.
An oral anti-clotting drug, when added to standard medical treatment for acute coronary syndrome, lowered the risk of death, heart attack or stroke an average of 16 percent, according to research presented at the American Heart Association's Scientific Sessions.
Tetra Discovery Partners today announced that the company has initiated human Phase 1 safety trials of its lead compound BPN14770, which Tetra is developing as a potential treatment to both improve memory and slow the progression of Alzheimer's disease.
› Verified 6 days ago
Amy M Stowe, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 795 Middle St, Fall River, MA 02721 Phone: 508-235-5258 Fax: 508-675-5671 | |
Mrs. Christine Carlin Celone, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 363 Highland Ave, Fall River, MA 02720 Phone: 508-679-3131 Fax: 508-679-7146 | |
Mr. Paul J Angelo, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 363 Highland Ave, Fall River, MA 02720 Phone: 508-679-3131 Fax: 508-679-7146 | |
Susan Jean Augustus, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 795 Middle St, Fall River, MA 02721 Phone: 508-235-5258 Fax: 508-675-5671 | |
Mrs. Jacqueline M Mula, C.R.N.A Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 363 Highland Ave, Fall River, MA 02720 Phone: 508-679-3131 Fax: 508-679-7146 | |
Keith Steven Buehler, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 363 Highland Ave, Fall River, MA 02720 Phone: 508-973-7014 | |
Karen Pauline Helgeland, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 363 Highland Ave, Fall River, MA 02720 Phone: 508-679-3131 |